Calcitonin gene related peptide receptor antagonists - Pfizer
Latest Information Update: 12 Mar 2026
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Calcitonin gene-related peptide receptor antagonists
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Unspecified
Most Recent Events
- 24 Nov 2025 Phase-I clinical trials in Unspecified (In volunteers) in USA (unspecified route) (NCT07261371)